Pharmabiz2d
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments
DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...
Pharmabiz2d
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...
Pharmabiz2d
Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb
Telix, a commercial-stage biopharmaceutical company, announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next ...
Pharmabiz5h
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy: Paris, France Thursday, January 16, 2025, 18:00 Hrs [IST] ...
Pharmabiz2d
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...
Pharmabiz6h
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries: Malvern, Pennsylvania Thursday, January 16, 2025, 17:00 Hrs [IST] Anno ...
Pharmabiz7d
Parliamentary panel asks PMBI to take steps to ensure quality of drugs sold through JAKs
The Parliamentary panel that reviewed the budget allocation for the Department of Pharmaceuticals (DoP) and related matters has sought the Pharmaceuticals & Medical Devices Bureau of India (PMBI), the ...
Pharmabiz6d
FPME demands policy reforms to address critical issues hampering export ecosystem
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has urged the authorities to address critical issues hampering India's pharmaceutical export ecosystem, highlighting the ...
Pharmabiz6d
AIPPSPA urges Kerala DCA to carry out separate inspections at discount pharmacies to ensure quality of drugs
Expressing concerns over the quality of medicines sold through discount pharmacies in Kerala, the state president of the All India Public and Private Sector Pharmacists Association (AIPPSPA), ...
Pharmabiz6d
AI to revolutionise hair loss diagnosis and treatment, say experts
The integration of AI marks a significant leap in diagnosing complex hair loss conditions, personalizing treatments, and offering predictive insights that foster better patient adherence and ...
Pharmabiz7d
Adcentrx begins patient dosing in phase 1a/b study of ADRX-0405, a potential first-in-class ADC targeting STEAP1 to treat advanced solid tumours
Adcentrx Therapeutics (Adcentrx), a clinical-stage biotechnology company advancing innovative protein conjugates for cancer and other life-threatening diseases, announced the first patient dosed in ...
Pharmabiz6d
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, announced progress across its pipeline ...